Literature DB >> 23073268

Advances in hematopoietic stem cell transplantation in childhood and adolescent lymphomas.

Mitchell S Cairo1, Willi Woessmann, John Pagel.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23073268      PMCID： PMC3700343          DOI： 10.1016/j.bbmt.2012.10.003

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  30 in total

Review 1.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A M Carella; M Cavaliere; E Lerma; R Ferrara; L Tedeschi; A Romanelli; M Vinci; G Pinotti; P Lambelet; C Loni; S Verdiani; F De Stefano; M Valbonesi; M T Corsetti
Journal:  J Clin Oncol       Date:  2000-12-01       Impact factor: 44.544

3.  Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development.

Authors:  Tetsuya Mori; Nobutaka Kiyokawa; Hiroyuki Shimada; Jun Miyauchi; Junichiro Fujimoto
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

4.  Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Authors:  Barbara Pro; Ranjana Advani; Pauline Brice; Nancy L Bartlett; Joseph D Rosenblatt; Tim Illidge; Jeffrey Matous; Radhakrishnan Ramchandren; Michelle Fanale; Joseph M Connors; Yin Yang; Eric L Sievers; Dana A Kennedy; Andrei Shustov
Journal:  J Clin Oncol       Date:  2012-05-21       Impact factor: 44.544

5.  Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Authors:  K Seidemann; M Tiemann; M Schrappe; E Yakisan; I Simonitsch; G Janka-Schaub; W Dörffel; M Zimmermann; G Mann; H Gadner; R Parwaresch; H Riehm; A Reiter
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

6.  Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.

Authors:  L Brugières; P Quartier; M C Le Deley; H Pacquement; Y Perel; C Bergeron; C Schmitt; J Landmann; C Patte; M J Terrier-Lacombe; G Delsol; O Hartmann
Journal:  Ann Oncol       Date:  2000-01       Impact factor: 32.976

7.  Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

Authors:  A Reiter; M Schrappe; M Tiemann; R Parwaresch; M Zimmermann; E Yakisan; R Dopfer; P Bucsky; G Mann; H Gadner
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

8.  Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.

Authors:  P J Bierman; J M Vose; P K Leichner; S M Quadri; J O Armitage; J L Klein; R A Abrams; K A Dicke; H M Vriesendorp
Journal:  J Clin Oncol       Date:  1993-04       Impact factor: 44.544

Review 9.  Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.

Authors:  Denise M Williams; Rachel Hobson; John Imeson; Mary Gerrard; Keith McCarthy; C Ross Pinkerton
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

10.  Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

Authors:  R J Jones; R F Ambinder; S Piantadosi; G W Santos
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113
View more
  3 in total

Review 1.  Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma.

Authors:  Yaya Chu; Aliza Gardenswartz; Amanda M Termuhlen; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2019-01-06       Impact factor: 6.998

2.  Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma.

Authors:  Naoto Fujita; Ryoji Kobayashi; Yoshiko Atsuta; Fuminori Iwasaki; Junji Suzumiya; Yoji Sasahara; Masami Inoue; Katsuyoshi Koh; Tsukasa Hori; Hiroaki Goto; Tatsuo Ichinohe; Yoshiko Hashii; Koji Kato; Ritsuro Suzuki; Tetsuo Mitsui
Journal:  Int J Hematol       Date:  2019-01-30       Impact factor: 2.490

3.  Regulation of Osteogenic Differentiation of Placental-Derived Mesenchymal Stem Cells by Insulin-Like Growth Factors and Low Oxygen Tension.

Authors:  Amer Youssef; Victor K M Han
Journal:  Stem Cells Int       Date:  2017-09-12       Impact factor: 5.443
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.